Premium Information is available for this item - Upgrade for $1 a day
6505-01-266-9387
Theophylline Extended-Release Tablets
6505012669387 012669387 THEOLAIR TABLETS 0343-80 NDC00089-0343-80
January 2023
4
Marketplace 6505-01-266-9387
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-266-9387 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-266-9387 RQST Updated Every Day 6505-01-266-9387 RQST NE Related
Every Day 6505-01-266-9387 RQST NE Related Every Day 6505-01-266-9387 RQST NE Related Every Day 6505
/fsg-65/fsc-6505/us
THEOLAIR https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-266-9387 Theophylline Extended-Release
Tablets your Account Upgrade 6505-01-266-9387Theophylline Extended-Release Tablets6505012669387 012669387
www.nsnlookup.com /fsg-43/fsc-4310/fr 4310-14-380-5971 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-266-9387
4310143805971143805971 JavaScript in your web browser . 4310-14-380-5971Retenue Soupape Com4310143805971 1438059711614-0343-80
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-266-9388 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-266-9387
THEOLAIR TABLETS THEOLAIR TABLETS your Account Upgrade 6505-01-149-3555Usp Theophylline Tablets6505011493555
/fsg-65/fsc-6505/us
Restrictions 6505-01-266-9387
6505-01-266-9387 is a Theophylline Extended-Release Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-266-9387
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-266-9387
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-266-9387
- Part Number
- Manufacturer
- Status
- 0343-80
- Manufacturer
- 04515 - 3M Company Health Care/Mfg (Active)
- Primary Buy
- Primary Buy
- NDC00089-0343-80
- 04515 - 3M Company Health Care/Mfg (Active)
- Primary Buy
- Primary Buy
- THEOLAIR TABLETS
- 04515 - 3M Company Health Care/Mfg (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-266-9387
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 300.000 Milligrams Theophylline Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
- Therapeutic Equivalent [THPE]
- Theolair Sr By Riker Labs.,Inc.
- Special Features [FEAT]
- Long Action Mehtod:Extended Release;Scoring Characteristics:Half-Scored;
Management Data 6505-01-266-9387
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1987
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Tt
- 00000001000TT
- K
NATO Stock Numbers Related to 6505-01-266-9387
Freight Information 6505-01-266-9387
6505-01-266-9387 has freight characteristics.. 6505-01-266-9387 has a variance between NMFC and UFC when transported by rail and the description should be consulted.